PUNE, India, December 18, 2017 /PRNewswire/ --
Blood Glucose Monitoring System Market is forecast to reach $10.58 billion by 2022 from $8.35 billion in 2017 at a CAGR of 4.8% during (2017-2022) driven by rising prevalence of diabetic population, and increasing innovative product launches resulting in increased adoption amongst patients; while in 2017, the self-monitoring blood glucose system segment is expected to account for the largest share of the global market.
Browse 160 Market Data Tables and 46 Figures spread through 181 Pages and in-depth TOC on "Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022" http://www.reportsnreports.com/reports/1257536-blood-glucose-monitoring-system-market-by-product-self-monitoring-continuous-glucose-monitoring-devices-testing-site-fingertip-patient-care-setting-hospital-homecare-application-type-1-type-2-gestation-st-to-2022.html.
The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), Life Scan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
The blood glucose monitoring system market in North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.
Inquire for DISCOUNT on "Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=1257536.
Based on patient care setting, the blood glucose monitoring system market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market during the forecast period (2017-2022). This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.
Based on application, the Blood Glucose Monitoring System Market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 1 diabetes segment is expected to grow at a highest CAGR during the forecast period (2017-2022) owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.
The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Order a copy of "Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022" research report at http://www.reportsnreports.com/purchase.aspx?name=1257536.
North America accounted largest share of the blood glucose monitoring system market in 2017 followed by Europe. The report covers comprehensive information on the product portfolios of the top players in the blood glucose monitoring system market. The report analyzes the market based on product, testing site, patient care setting, and application.
On the basis of testing site, the blood glucose monitoring system market is segmented into fingertip testing and alternate site testing. Break of primary participants was as mentioned below:
Explore more reports on Medical Devices Market at http://www.reportsnreports.com/market-research/medical-devices/.
Advertisement
Blood Glucose Monitoring System Market is forecast to reach $10.58 billion by 2022 from $8.35 billion in 2017 at a CAGR of 4.8% during (2017-2022) driven by rising prevalence of diabetic population, and increasing innovative product launches resulting in increased adoption amongst patients; while in 2017, the self-monitoring blood glucose system segment is expected to account for the largest share of the global market.
Advertisement
Browse 160 Market Data Tables and 46 Figures spread through 181 Pages and in-depth TOC on "Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022" http://www.reportsnreports.com/reports/1257536-blood-glucose-monitoring-system-market-by-product-self-monitoring-continuous-glucose-monitoring-devices-testing-site-fingertip-patient-care-setting-hospital-homecare-application-type-1-type-2-gestation-st-to-2022.html.
The key players in the global blood glucose monitoring system market are Roche (Switzerland), Abbott (US), Life Scan (US), Ascensia (Switzerland), Medtronic (Ireland), Dexcom (US), Ypsomed (Switzerland), B. Braun (Germany), Nipro (Japan), Sanofi (France), ARKRAY (Japan), Prodigy Diabetes Care (US), ACON Laboratories (US), and Nova Biomedical (US).
The blood glucose monitoring system market in North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs and rising FDA approvals in the US.
Inquire for DISCOUNT on "Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022" research report at http://www.reportsnreports.com/contacts/discount.aspx?name=1257536.
Based on patient care setting, the blood glucose monitoring system market is segmented into self/home care and hospitals/clinics. The self/home care segment is expected to account for the largest share of the blood glucose monitoring system market during the forecast period (2017-2022). This can be attributed to high adoption of these devices for home use owing to technological advancements increasing their accuracy and patient comfort.
Based on application, the Blood Glucose Monitoring System Market is segmented into type 1 diabetes, type 2 diabetes, and gestational diabetes. The type 1 diabetes segment is expected to grow at a highest CAGR during the forecast period (2017-2022) owing to increasing product launches of continuous glucose monitors that are used for better management of type 1 diabetes.
The report analyzes the blood glucose monitoring system market and aims at estimating the market size and future growth potential of this market based on various segments such as product, testing site, patient care setting, application, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.
Order a copy of "Blood Glucose Monitoring System Market by Product (Self-Monitoring, Continuous Glucose Monitoring Devices), Testing Site (Fingertip), Patient Care Setting (Hospital, Homecare), Application (Type 1, Type 2, Gestational Diabetes) - Global Forecast to 2022" research report at http://www.reportsnreports.com/purchase.aspx?name=1257536.
North America accounted largest share of the blood glucose monitoring system market in 2017 followed by Europe. The report covers comprehensive information on the product portfolios of the top players in the blood glucose monitoring system market. The report analyzes the market based on product, testing site, patient care setting, and application.
On the basis of testing site, the blood glucose monitoring system market is segmented into fingertip testing and alternate site testing. Break of primary participants was as mentioned below:
- By Company Type: Tier 1 - 50%, Tier 2 - 30% and Tier 3 - 20%
- By Designation: C-level - 30%, Director Level - 48%, Others - 22%
- By Region: North America - 48%, Europe - 20%, Asia-Pacific - 25%, Row - 7%
Explore more reports on Medical Devices Market at http://www.reportsnreports.com/market-research/medical-devices/.
About Us:
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
Contact:
Hrishikesh Patwardhan
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Maharashtra, India.
+1-888-391-5441
[email protected]
Connect with Us:
LinkedIn:
www.linkedin.com/company/reportsnreports
RSS/Feeds:
http://www.reportsnreports.com/feed/l-latestreports.xml
SOURCE ReportsnReports
